TYMS and breast cancer: Similarly, the nucleotide metabolic enzyme thymidylate synthase (TS), which is generally associated with cell proliferation, has been found to govern the EMT phenotype and breast cancer de-differentiation, requiring DPYD-dependent pyrimidine catabolism [145].